The aim of study is evaluation of the effect of vitamin D supplementation on serum hepatic enzymes, oxidative stress indicators & inflammatory markers in patients with Non-Alcoholic Fatty Liver Disease
Study design is double blind placebo controlled randomized clinical trial
The study sample includes 60 patients (30 in intervention and 30 in control group) diagnosed with non alcoholic fatty liver disease of both gender
Inclusion Criteria : diagnosis to have non alcoholic fatty liver disease ages above 18 and serum alanine transaminase enzyme level higher than normal (> 40 U/L).
Exclusion criteria: Alcohol consumption greater than 20 g per day, pregnancy, lactation, having other hepatic diseases, using hepatotoxic drugs and consumption of vitamin D,vitamin E and calcium supplementation during last 6 months.
Intervention: One pearl of vitamin D supplement contains 50000 IU vitamin D will be prescribed every other week for 4 months in intervention group. One placebo contains edible paraffin will be prescribed every other week for 4 months in control group.
Primary Outcomes: Serum levels of hepatic enzymes include Alanine transaminase, Aspartate transaminase and alkaline phosphatase.
Secondary Outcomes: Insulin resistance, Tumor necrosis factor α, Transforming growth factor β, hs-CRP, Adiponectin, Total antioxidant capacity, Malondialdehyde, Cytokeratin-18, Lipid profile, serum level of vitamin D.